EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Optimal Oversizing With the New-Generation Evolut (PRO/PRO+/FX) Self-Expanding Valves: A Multicenter Study

Silvia Mas-Peiro iD, Alberto Alperi iD, Ander Regueiro, Ignacio Cruz-Gonzalez iD, Domenico Angellotti iD, Francisco Campelo-Parada iD, Marina Urena iD, Pablo Avanzas iD, Pablo Vidal-Cales iD, Gilles Jose Barreira de Sousa, Giovanni Esposito iD, Mehdi Tamir und 5 weitere

Circulation: Cardiovascular Interventions · 2025

DOI: 10.1161/circinterventions.124.014916 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Circulation: Cardiovascular Interventions, 2025. Verfasst von Silvia Mas-Peiro und 16 weiteren Autor:innen. Beteiligte Einrichtung: Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada (S.M.-P., A.P., S.M., M.A., J.R.-C.). Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Heart Valve Prosthesis, Aortic Valve, Aortic Valve Stenosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Paravalvular leaks (PVLs) after transcatheter aortic valve replacement have a significant prognostic impact, and valve oversizing, particularly with self-expanding valves, may prevent postprocedural PVL occurrence. Recent iterations of the Evolut valve system are intended to reduce PVL, but the effects of oversizing with such valves on PVL are largely unknown. We aimed to assess, in a real-world contemporary setting, the impact of Evolut valve oversizing on PVL after transcatheter aortic valve replacement. METHODS: This was a multicenter observational ambispective study of patients undergoing transcatheter aortic valve replacement with the Evolut PRO/PRO+/FX valves. Aortic annulus perimeter, as determined by multidetector computed tomography, was used to estimate the oversizing degree. The primary end point was the presence of PVL (mild/moderate-severe), as determined by echocardiography at hospital discharge. Secondary end points included in-hospital outcomes as defined by the Valve Academic Research Consortium-3 recommendations. RESULTS: A total of 762 patients were included (Evolut PRO/PRO+/FX, 55.5%/34.8%/9.7%), and the median valve oversizing was 20 (17–25)%, with no differences in baseline characteristics between low (≤20%, n=381) and high (>20%, n=381) valve oversizing recipients. In-hospital mortality and stroke rates were 2.4% and 4.3%, respectively, with no oversizing-related differences in clinical outcomes. Permanent pacemaker rates were similar in patients with low (19.4%) and high (15.8%) valve oversizing, P =0.21. PVL was found in 35.6% of patients (mild: 32.6%, moderate-severe: 3.0%), with a higher incidence of PVL in patients with low (40.9%) versus high (30.2%) oversizing, P =0.002. In a multivariable analysis, a higher oversizing degree was associated with a lower risk of PVL (odds ratio, 0.95 [0.92–0.99] for each 1% increase in oversizing, P =0.006). CONCLUSIONS: In transcatheter aortic valve replacement with recent Evolut valve iterations (PRO/PRO+/FX), a higher oversizing degree was associated with a lower frequency of PVL without increasing the risk of other complications (including permanent pacemaker). These data suggest that a low degree of valve oversizing should probably be avoided when using Evolut valves, particularly in borderline cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementHeart Valve ProsthesisAortic ValveAortic Valve StenosisAortic Valve InsufficiencyHumansMaleFemaleAgedProsthesis DesignAged, 80 and overTreatment OutcomeRisk FactorsTime FactorsMultidetector Computed TomographyRisk Assessment

Stichwörter der Autor:innen

aortic regurgitationaortic valve stenosisoversizingtranscatheter aortic valve replacement

Autor:innen und Institutionen

  • Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada (S.M.-P., A.P., S.M., M.A., J.R.-C.).
  • Cardiology Department, Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain (A.A., P.A.).
  • Cardiology Department, Instituto Clínic Cardiovascular, Hospital Clínic, Barcelona, Spain (A.R., P.V.-C., J.R.-C.).
  • Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain (A.R., P.V.-C., J.R.-C.).
  • Cardiology Department, Hospital Universitario de Salamanca, IBSAL, CIBER CV, Spain (I.C.-G., G.J.B.S.).
  • Department of Advanced Biomedical Sciences, Federico II University of Naples, Italy (D.A., G.E.).

ORCID-Profile: Silvia Mas-Peiro, Alberto Alperi, Ignacio Cruz-Gonzalez, Domenico Angellotti, Francisco Campelo-Parada, Marina Urena, Pablo Avanzas, Pablo Vidal-Cales, Giovanni Esposito, Gaspard Suc, Siamak Mohammadi, Marisa Avvedimento, Josep Rodés-Cabau

Zitieren

APA

Mas-Peiro, S., Alperi, A., Regueiro, A., Cruz-Gonzalez, I., Angellotti, D., Campelo-Parada, F., Urena, M., Avanzas, P., Vidal-Cales, P., Barreira de Sousa, G. J., Esposito, G., Tamir, M., Suc, G., Poulin, A., Mohammadi, S., Avvedimento, M., & Rodés-Cabau, J. (2025). Optimal Oversizing With the New-Generation Evolut (PRO/PRO+/FX) Self-Expanding Valves: A Multicenter Study. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.124.014916

Vancouver

Mas-Peiro S, Alperi A, Regueiro A, Cruz-Gonzalez I, Angellotti D, Campelo-Parada F, et al. Optimal Oversizing With the New-Generation Evolut (PRO/PRO+/FX) Self-Expanding Valves: A Multicenter Study. Circulation: Cardiovascular Interventions. 2025. doi:10.1161/circinterventions.124.014916

BibTeX
@article{MasPeiro2025,
  author = {Mas-Peiro, Silvia and Alperi, Alberto and Regueiro, Ander and Cruz-Gonzalez, Ignacio and Angellotti, Domenico and Campelo-Parada, Francisco and Urena, Marina and Avanzas, Pablo and Vidal-Cales, Pablo and Barreira de Sousa, Gilles Jose and Esposito, Giovanni and Tamir, Mehdi and Suc, Gaspard and Poulin, Anthony and Mohammadi, Siamak and Avvedimento, Marisa and Rodés-Cabau, Josep},
  title = {Optimal Oversizing With the New-Generation Evolut (PRO/PRO+/FX) Self-Expanding Valves: A Multicenter Study},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2025},
  doi = {10.1161/circinterventions.124.014916}
}
Kostenlos starten →